Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
2.750
-0.030 (-1.08%)
Dec 20, 2024, 4:00 PM EST - Market closed
Puma Biotechnology Market Cap
Puma Biotechnology has a market cap or net worth of $134.99 million as of December 20, 2024. Its market cap has decreased by -32.10% in one year.
Market Cap
134.99M
Enterprise Value
124.64M
1-Year Change
-32.10%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since April 24, 2012, Puma Biotechnology's market cap has decreased from $280.60M to $134.99M, a decrease of -51.89%. That is a compound annual growth rate of -5.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 135.00M | -34.47% |
| Dec 29, 2023 | 206.00M | 6.68% |
| Dec 30, 2022 | 193.10M | 55.35% |
| Dec 31, 2021 | 124.30M | -69.53% |
| Dec 31, 2020 | 408.00M | 19.68% |
| Dec 31, 2019 | 340.90M | -56.07% |
| Dec 31, 2018 | 776.00M | -79.08% |
| Dec 29, 2017 | 3.71B | 228.21% |
| Dec 30, 2016 | 1.13B | -55.55% |
| Dec 31, 2015 | 2.54B | -55.43% |
| Dec 31, 2014 | 5.71B | 92.11% |
| Dec 31, 2013 | 2.97B | 452.60% |
| Dec 31, 2012 | 537.50M | 91.55% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pro-Dex | 143.35M |
| Actuate Therapeutics | 142.19M |
| Monopar Therapeutics | 141.92M |
| Nevro | 139.02M |
| Aligos Therapeutics | 137.66M |
| Metagenomi | 136.22M |
| Telomir Pharmaceuticals | 135.91M |
| Vaxart | 135.87M |